Amicus Therapeutics, Inc
Symbol: FOLD (NASDAQ)
Company Description:
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $7.94
- Yesterday High: $8.11
- Yesterday Low: $7.785
- Yesterday Volume: 3.54M
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
- Name: Amicus Therapeutics, Inc
- Website: https://www.amicusrx.com
- Listed Date: 2007-05-31
- Location: PRINCETON, NJ
- Market Status: Active
- CIK Number: 0001178879
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.45B
- Round Lot: 100
- Outstanding Shares: 308.24M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-25 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-05 | S-8 | View |
| 2025-06-05 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-09 | SCHEDULE 13G/A | View |
| 2025-05-01 | 10-Q | View |
| 2025-05-01 | 8-K | View |
| 2025-05-01 | 8-K | View |